PHARMACAM: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMACAM
Largest movements
- Receivables within one year +€62,803
up €62,803 (+73.5%), from €85,424 to €148,227
of which Other amounts receivable: +€44,789
- Deferred charges and accrued income -€55,000
down €55,000 (-100%), from €55,000 to €0
- Tangible fixed assets +€29,775
up €29,775 (+41.2%), from €72,228 to €102,004
of which Land and buildings: +€31,448
- Stocks and contracts -€18,742
down €18,742 (-15.0%), from €124,792 to €106,050
- Cash +€16,894
up €16,894 (+45.1%), from €37,450 to €54,344
mainly Deferred charges and accrued income (+€55,000) and Trade debts (+€35,907)
- Trade debts +€35,907
up €35,907 (+86.8%), from €41,351 to €77,258
- Reserves -€27,913
down €27,913 (-11.8%), from €236,864 to €208,950
- Other debts +€22,541
up €22,541 (+237%), from €9,505 to €32,047
- Tax, wage and social debts +€5,195
up €5,195 (+30.0%), from €17,324 to €22,519
of which Remuneration and social security: +€5,469
- Gross operating margin -€44,528
down €44,528 (-27.3%), from €162,878 to €118,350
- Taxes -€6,529
down €6,529 (-100%), from €6,529 to €0
- Depreciation +€5,365
up €5,365 (+62.5%), from €8,590 to €13,955
- Staff costs +€4,786
up €4,786 (+3.7%), from €127,750 to €132,536
- Financial income +€2,999
up €2,999 (+11,885%), from €25 to €3,024
of which Non-recurring financial income: +€2,558
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €374,894 | €410,625 | +€35,731 | +9.5% |
| Fixed assets | 21/28 | €72,228 | €102,004 | +€29,775 | +41.2% |
| Tangible fixed assets | 22/27 | €72,228 | €102,004 | +€29,775 | +41.2% |
| Land and buildings | 22 | €67,708 | €99,155 | +€31,448 | +46.4% |
| Furniture and vehicles | 24 | €4,521 | €2,848 | -€1,672 | -37.0% |
| Current assets | 29/58 | €302,666 | €308,621 | +€5,955 | +2.0% |
| Stocks and contracts in progress | 3 | €124,792 | €106,050 | -€18,742 | -15.0% |
| Stocks | 30/36 | €124,792 | €106,050 | -€18,742 | -15.0% |
| Amounts receivable within one year | 40/41 | €85,424 | €148,227 | +€62,803 | +73.5% |
| Trade receivables | 40 | €82,770 | €100,784 | +€18,014 | +21.8% |
| Other amounts receivable | 41 | €2,654 | €47,443 | +€44,789 | +1,688% |
| Cash at bank and in hand | 54/58 | €37,450 | €54,344 | +€16,894 | +45.1% |
| Deferred charges and accrued income | 490/1 | €55,000 | €0 | -€55,000 | -100% |
| Total equity and liabilities | 10/49 | €374,894 | €410,625 | +€35,731 | +9.5% |
| Equity | 10/15 | €306,714 | €278,801 | -€27,913 | -9.1% |
| Contributions | 10/11 | €69,850 | €69,850 | = | 0.0% |
| Reserves | 13 | €236,864 | €208,950 | -€27,913 | -11.8% |
| Distributable reserves | 133 | €236,864 | €208,950 | -€27,913 | -11.8% |
| Amounts payable | 17/49 | €68,180 | €131,824 | +€63,644 | +93.3% |
| Amounts payable within one year | 42/48 | €68,180 | €131,824 | +€63,644 | +93.3% |
| Trade debts | 44 | €41,351 | €77,258 | +€35,907 | +86.8% |
| Suppliers | 440/4 | €41,351 | €77,258 | +€35,907 | +86.8% |
| Taxes, remuneration and social security | 45 | €17,324 | €22,519 | +€5,195 | +30.0% |
| Taxes | 450/3 | €274 | €0 | -€274 | -100% |
| Remuneration and social security | 454/9 | €17,050 | €22,519 | +€5,469 | +32.1% |
| Other amounts payable | 47/48 | €9,505 | €32,047 | +€22,541 | +237% |
| Remuneration, social security and pensions | 62 | €127,750 | €132,536 | +€4,786 | +3.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,590 | €13,955 | +€5,365 | +62.5% |
| Other operating charges | 640/8 | €1,255 | €2,391 | +€1,136 | +90.5% |
| Gross operating margin | 9900 | €162,878 | €118,350 | -€44,528 | -27.3% |
| Operating profit (loss) | 9901 | €25,283 | -€30,531 | -€55,814 | |
| Financial income | 75/76B | €25 | €3,024 | +€2,999 | +11,885% |
| Recurring financial income | 75 | €25 | €440 | +€415 | +1,645% |
| Non-recurring financial income | 76B | €25 | €2,584 | +€2,558 | +10,140% |
| Financial charges | 65/66B | €2,190 | €406 | -€1,784 | -81.5% |
| Recurring financial charges | 65 | €1,860 | €402 | -€1,458 | -78.4% |
| Non-recurring financial charges | 66B | €330 | €4 | -€326 | -98.7% |
| Profit (loss) for the period before taxes | 9903 | €23,118 | -€27,913 | -€51,032 | |
| Income taxes | 67/77 | €6,529 | €0 | -€6,529 | -100% |
| Profit (loss) for the period | 9904 | €16,589 | -€27,913 | -€44,502 | |
| Profit (loss) for the period to be appropriated | 9905 | €16,589 | -€27,913 | -€44,502 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.